Healthcare provider profile · identity verified

Kaushal Kalra, MD

Family Practice · MEMPHIS, TN · NPI 1467896506

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	636	212
Amlodipine Besylate	Amlodipine Besylate	547	183
Losartan Potassium	Losartan Potassium	287	88
Hydrochlorothiazide	Hydrochlorothiazide	266	81
Omeprazole	Omeprazole	259	88
Lisinopril	Lisinopril	210	64
Metoprolol Tartrate	Metoprolol Tartrate	163	57
Gabapentin	Gabapentin	156	42
Simvastatin	Simvastatin	147	43
Metformin Hcl	Metformin Hcl	137	44
Allopurinol	Allopurinol	130	38
Fluticasone Propionate	Fluticasone Propionate	111	48
Mounjaro	Tirzepatide	111	17
Levothyroxine Sodium	Levothyroxine Sodium	106	34
Hydralazine Hcl	Hydralazine Hcl	105	38
Clonidine Hcl	Clonidine Hcl	97	27
Albuterol Sulfate Hfa	Albuterol Sulfate	91	42
Meloxicam	Meloxicam	89	30
Pantoprazole Sodium	Pantoprazole Sodium	89	38
Tamsulosin Hcl	Tamsulosin Hcl	89	30
Benazepril Hcl	Benazepril Hcl	87	26
Rosuvastatin Calcium	Rosuvastatin Calcium	86	28
Pravastatin Sodium	Pravastatin Sodium	84	27
Furosemide	Furosemide	82	29
Carvedilol	Carvedilol	80	26
Jardiance	Empagliflozin	80	22
Montelukast Sodium	Montelukast Sodium	75	21
Metoprolol Succinate	Metoprolol Succinate	73	28
Ozempic	Semaglutide	72	19
Potassium Chloride	Potassium Chloride	65	21
Metformin Hcl Er	Metformin Hcl	64	20
Atenolol	Atenolol	62	16
Famotidine	Famotidine	62	22
Alendronate Sodium	Alendronate Sodium	58	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	57	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	56	15
Trazodone Hcl	Trazodone Hcl	56	20
Nifedipine Er	Nifedipine	49	14
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	48	18
Fluoxetine Hcl	Fluoxetine Hcl	47	11
Clopidogrel	Clopidogrel Bisulfate	45	12
Genvoya	Elviteg/Cob/Emtri/Tenof Alafen	43	suppressed
Ibuprofen	Ibuprofen	43	11
Farxiga	Dapagliflozin Propanediol	42	13
Fenofibrate	Fenofibrate Nanocrystallized	42	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	39	12
Glipizide Er	Glipizide	37	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	36	23
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	35	20
Ezetimibe	Ezetimibe	35	15
Citalopram Hbr	Citalopram Hydrobromide	34	suppressed
Methylprednisolone	Methylprednisolone	34	31
Olmesartan Medoxomil	Olmesartan Medoxomil	34	suppressed
Eliquis	Apixaban	31	15
Valsartan	Valsartan	31	suppressed
Spironolactone	Spironolactone	30	11
Pregabalin	Pregabalin	27	suppressed
Azithromycin	Azithromycin	26	23
Levofloxacin	Levofloxacin	25	23
Hydroxyzine Hcl	Hydroxyzine Hcl	24	11
Xarelto	Rivaroxaban	24	suppressed
Finasteride	Finasteride	23	suppressed
Prezcobix	Darunavir/Cobicistat	23	suppressed
Trulicity	Dulaglutide	23	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	23	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	20
Darunavir	Darunavir	22	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	20
Glimepiride	Glimepiride	21	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Nateglinide	Nateglinide	21	suppressed
Ketoconazole	Ketoconazole	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Tizanidine Hcl	Tizanidine Hcl	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	18
Doxepin Hcl	Doxepin Hcl	19	suppressed
Duloxetine Hcl	Duloxetine Hcl	19	suppressed
Glipizide	Glipizide	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Sertraline Hcl	Sertraline Hcl	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	18	suppressed
Triumeq	Abacavir/Dolutegravir/Lamivudi	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	17	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Clonidine	Clonidine	17	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	17	suppressed
Efavirenz-Emtric-Tenofov Disop	Efavirenz/Emtricit/Tenofovr Df	17	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Topiramate	Topiramate	17	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	17	suppressed
Colchicine	Colchicine	16	suppressed
Isentress	Raltegravir Potassium	16	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	16	suppressed
Ramipril	Ramipril	16	suppressed
Baclofen	Baclofen	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Diclofenac Potassium	Diclofenac Potassium	15	suppressed
Emtricitabine-Tenofovir Disop	Emtricitabine/Tenofovir (Tdf)	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Fluconazole	Fluconazole	14	11
Janumet	Sitagliptin Phos/Metformin Hcl	14	suppressed
Linzess	Linaclotide	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Ciclopirox	Ciclopirox	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	12	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	12	suppressed
Bevespi Aerosphere	Glycopyrrolate/Formoterol Fum	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Estradiol	Estradiol	12	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error